Choosing the Right Patient for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis: Endotypes, Patient Characteristics, and Defining Failures of Standard Therapy

Otolaryngol Clin North Am. 2021 Aug;54(4):701-708. doi: 10.1016/j.otc.2021.04.008. Epub 2021 Jun 9.

Abstract

There are many phenotypes of chronic sinusitis and clinical variables that differ between patients. The ability to accurately diagnose, predict prognosis, and select the appropriate treatment depends on the understanding of disease endotypes. Chronic sinusitis is in the early stages of disease endotyping. The ability to identify endotypes is at the forefront of clinical research. Endotyping of chronic sinusitis uses clinical information, radiographic studies, and pathophysiologic data. Understanding of the full spectrum of chronic sinusitis is in its infancy. A personalized approach to treatment will consider standard medical therapies, sinus surgeries, and targeted use of biologic agents.

Keywords: Biologics; Endotypes; Polyps; Sinus surgery; Sinusitis.

Publication types

  • Review

MeSH terms

  • Biological Therapy
  • Chronic Disease
  • Humans
  • Nasal Polyps* / drug therapy
  • Rhinitis* / drug therapy
  • Sinusitis* / drug therapy